id,disease_progression_status,survival_status,clinical_response_rate_target_lasion,clinical_response_rate_non_target_lasion,clinical_response_rate_new_lasion,clinical_response_rate_result,radiological_response_rate_target_lasion,radiological_response_rate_non_target_lasion,radiological_response_rate_new_lasion,radiological_response_rate_result,pathological_response_rate_target_lasion,pathological_response_rate_non_target_lasion,pathological_response_rate_new_lasion,pathological_response_rate_result,time,registration_number,laterality,current_chemo_protocol,chemo_starting_date,chemo_cycle_no,chemo_detail,disease_progression_status_date,pfs,survival_status_date,overall_survival,clinical_response_rate_date,radiological_response_rate_date,pathological_response_rate_date,cancer_type,patient_id_id,patient_id_socio_economic_status_name,patient_id_unique_id,patient_id_name,patient_id_phone,patient_id_date_of_birth,patient_id_gender,patient_id_blood_group,patient_id_area,patient_id_police_station,patient_id_district,doctor_id_name,center_id_name,grade_name,line_of_treatment_name,diagnosis_disease_group_name,diagnosis_subgroup_diagnosis_disease_group_name,diagnosis_subgroup_name,diagnosis_primary_site_name,diagnosis_laterility_name,patient_id_socio_economic_status,grade,disease_progression_status_name,survival_status_name,clinical_response_rate_target_lasion_name,clinical_response_rate_non_target_lasion_name,clinical_response_rate_new_lasion_name,clinical_response_rate_result_name,radiological_response_rate_target_lasion_name,radiological_response_rate_non_target_lasion_name,radiological_response_rate_new_lasion_name,radiological_response_rate_result_name,diagnosis_laterility,line_of_treatment,diagnosis_subgroup,pathological_response_rate_target_lasion_name,pathological_response_rate_non_target_lasion_name,pathological_response_rate_new_lasion_name,pathological_response_rate_result_name,diagnosis_disease_group,diagnosis_primary_site,name,value,unit,date,patient_observation_id
849,,,,,,,,,,,,,,,2024-06-02T10:59:42+06:00,BSH - ,Right,Tamoxifen,,,,2024-03-11,,2024-03-11,,,,2023-01-19,Breast,135,Upper middle class,BSBSC-240000135,NOORUN NAHAR,1713147703,1981-01-28,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,,Continuous Maintenance,D05- Carcinoma In Situ of Breast,D05- Carcinoma In Situ of Breast,D05.1- Intraductal carcinoma in situ,Breast,Right,,,Stable,Alive,,,,,,,,,,,,CR,,,,,,CA15.3,6.5,,2022-08-03,849.0
849,,,,,,,,,,,,,,,2024-06-02T10:59:42+06:00,BSH - ,Right,Tamoxifen,,,,2024-03-11,,2024-03-11,,,,2023-01-19,Breast,135,Upper middle class,BSBSC-240000135,NOORUN NAHAR,1713147703,1981-01-28,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,,Continuous Maintenance,D05- Carcinoma In Situ of Breast,D05- Carcinoma In Situ of Breast,D05.1- Intraductal carcinoma in situ,Breast,Right,,,Stable,Alive,,,,,,,,,,,,CR,,,,,,CA15.3,19.9,,2023-01-19,849.0
849,,,,,,,,,,,,,,,2024-06-02T10:59:42+06:00,BSH - ,Right,Tamoxifen,,,,2024-03-11,,2024-03-11,,,,2023-01-19,Breast,135,Upper middle class,BSBSC-240000135,NOORUN NAHAR,1713147703,1981-01-28,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,,Continuous Maintenance,D05- Carcinoma In Situ of Breast,D05- Carcinoma In Situ of Breast,D05.1- Intraductal carcinoma in situ,Breast,Right,,,Stable,Alive,,,,,,,,,,,,CR,,,,,,CA15.3,16.5,,2023-05-01,849.0
849,,,,,,,,,,,,,,,2024-06-02T10:59:42+06:00,BSH - ,Right,Tamoxifen,,,,2024-03-11,,2024-03-11,,,,2023-01-19,Breast,135,Upper middle class,BSBSC-240000135,NOORUN NAHAR,1713147703,1981-01-28,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,,Continuous Maintenance,D05- Carcinoma In Situ of Breast,D05- Carcinoma In Situ of Breast,D05.1- Intraductal carcinoma in situ,Breast,Right,,,Stable,Alive,,,,,,,,,,,,CR,,,,,,CA15.3,18.6,,2023-08-30,849.0
849,,,,,,,,,,,,,,,2024-06-02T10:59:42+06:00,BSH - ,Right,Tamoxifen,,,,2024-03-11,,2024-03-11,,,,2023-01-19,Breast,135,Upper middle class,BSBSC-240000135,NOORUN NAHAR,1713147703,1981-01-28,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,,Continuous Maintenance,D05- Carcinoma In Situ of Breast,D05- Carcinoma In Situ of Breast,D05.1- Intraductal carcinoma in situ,Breast,Right,,,Stable,Alive,,,,,,,,,,,,CR,,,,,,CA15.3,14.5,,2024-02-26,849.0
139,,,,,,,,,,,,,,,2024-06-02T10:59:42+06:00,BSH - H12208275282,Right,Tamoxifen,,,,2024-03-11,,2024-03-11,,,,2023-01-19,Breast,135,Upper middle class,BSBSC-240000135,NOORUN NAHAR,1713147703,1981-01-28,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,,Continuous Maintenance,D05- Carcinoma In Situ of Breast,D05- Carcinoma In Situ of Breast,D05.1- Intraductal carcinoma in situ,Breast,Right,,,Stable,Alive,,,,,,,,,,,,CR,,,,,,,,,,
736,,,,,,,,,,,,,,,2024-06-02T10:59:42+06:00,BSH - H12208275282,Right,Tamoxifen,,,,2024-03-11,,2024-03-11,,,,2023-01-19,Breast,135,Upper middle class,BSBSC-240000135,NOORUN NAHAR,1713147703,1981-01-28,Female,,,,,Prof Dr Qamruzzaman Chowdhury,BSH,,Continuous Maintenance,D05- Carcinoma In Situ of Breast,D05- Carcinoma In Situ of Breast,D05.1- Intraductal carcinoma in situ,Breast,Right,,,Stable,Alive,,,,,,,,,,,,CR,,,,,,,,,,
